Vivek Govind Patel

Vivek Patel practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Vivek Patel's NPI, 1740716158, was assigned on May 4, 2017. Vivek Patel graduated from Vanderbilt University School of Medicine in 2017. Vivek Patel holds Tennessee license 67280.

Vivek Patel's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Vivek Patel's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Vivek Patel to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Vivek Patel practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Vivek Patel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Vivek Patel is licensed in Tennessee.

CMS data shows 461 Medicare services from Vivek Patel across 10 procedure codes in 2024, for 114 Medicare patients. Medicare paid $32,351 for them.

CMS counts 114 Medicare patients who saw Vivek Patel in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Vivek Patel's median patient age at 71, with 46% women.

In 2024, Vivek Patel wrote 260 Medicare Part D claims for 46 patients. 78% of them were for generic drugs. CMS names the drug for 129 of them, across 7 drugs with 11 or more claims each, at $575,038 in total drug cost. In 2018, CMS named 14 claims across 1 drug.

Vivek Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Vivek Patel as offering telehealth.

Dmand AI links 8 papers to Vivek Patel, published from 2016 to 2025. 2025 was the busiest year, with 2. The most frequent topics are Antigens, CD19, Lymphoma, Large B-Cell, Diffuse and Biological Products. Vivek Patel's most frequent co-authors are Shakthi Tapasya Bhaskar, MD, Daniel Jacob Hausrath and Loretta J. Nastoupil, MD.

CMS Open Payments shows 34 general payments to Vivek Patel from 7 drug and device companies from 2023 to 2025. Speaker and faculty fees make up the largest share, 41% of the total. Genmab U.S., Inc. paid the most, $7,977.

Vivek Patel graduated from Vanderbilt University School of Medicine in 2017.